Drug safety and drug efficacy: Two sides of the same coin

Clinical Cancer Research

Volumn 13, Issue 9, 2007, Pages 2533-2534

  Young, Robert C ^a   Friedman, Michael A ^b   Schilsky, Richard L ^c   Sigal, Ellen V ^d,e  

^a FOX CHASE CANCER CENTER   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d Friends of Cancer Research   (United States)

^e Friends of Cancer Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFORMATION TECHNOLOGY; LAW; MEDICAL CARE; ORGANIZATION; PHARMACEUTICAL CARE; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

DRUG EVALUATION; DRUG TOXICITY; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34249078327     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0608     Document Type: Editorial

References (0)